Trial site
Anderson Medical Research
- 11running trials
- 2closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease6 trials
- Stroke6 trials
- High blood pressure4 trials
- Familial hypercholesterolaemia3 trials
- Atrial fibrillation2 trials
- Chronic kidney disease2 trials
- Heart failure2 trials
- Obesity1 trial
- Peripheral artery disease1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 37 trials
- Phase 26 trials
- Status
- Active, not recruiting6 trials
- Recruiting5 trials
- Completed2 trials
- Lead sponsor
- Novartis Pharmaceuticals10 trials
- Regeneron Pharmaceuticals2 trials
- Eli Lilly and Company1 trial
Running trials
Recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Active, not recruiting
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation2 recruiting
- High blood pressure2 recruiting
- Stroke2 recruiting
- Chronic kidney disease1 recruiting
- Coronary artery disease1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Heart failure1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026